| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1558448 | 6480464 | Ethinyl Estradiol affects the expression of KDM4B mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1558448 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDM4B mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1558448 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDM4B mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1349901 | 6480464 | Tetrachlorodibenzodioxin affects the expression of KDM4B mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1558448 | 6480464 | Tetrachlorodibenzodioxin affects the expression of KDM4B mRNA | CTD | PMID:21570461 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1558448 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of KDM4B mRNA | CTD | PMID:20188158 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1349901 | 6480464 | KDM4B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| 5-fluorouracil | affects expression | ISO | RGD:1558448 | 6480464 | Fluorouracil affects the expression of KDM4B mRNA | CTD | PMID:20421339 |
| all-trans-retinoic acid | affects expression | ISO | RGD:1558448 | 6480464 | Tretinoin affects the expression of KDM4B mRNA | CTD | PMID:20421339 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1349901 | 6480464 | Benzo(a)pyrene results in decreased expression of KDM4B mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1349901 | 6480464 | Benzo(a)pyrene results in decreased expression of KDM4B mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | increases expression | ISO | RGD:1558448 | 6480464 | Benzo(a)pyrene results in increased expression of KDM4B mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1558448 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KDM4B mRNA] | CTD | PMID:22228805 |
| calcitriol | increases expression | ISO | RGD:1349901 | 6480464 | Calcitriol results in increased expression of KDM4B mRNA | CTD | PMID:16002434 |
| cisplatin | increases phosphorylation | ISO | RGD:1558448 | 6480464 | Cisplatin results in increased phosphorylation of KDM4B protein | CTD | PMID:22006019 |
| cisplatin | decreases expression | ISO | RGD:1349901 | 6480464 | Cisplatin results in decreased expression of KDM4B mRNA | CTD | PMID:19561079 |
| cobalt dichloride | multiple interactions | ISO | RGD:1349901 | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of KDM4B mRNA] | CTD | PMID:22202117 |
| cobalt dichloride | increases expression | ISO | RGD:1349901 | 6480464 | cobaltous chloride results in increased expression of KDM4B mRNA | CTD | PMID:19376846 PMID:22202117 |
| cobalt dichloride | increases expression | ISO | RGD:1349901 | 6480464 | cobaltous chloride results in increased expression of KDM4B mRNA | CTD | PMID:22202117 PMID:19376846 |
| cobalt dichloride | increases expression | ISO | RGD:1349901 | 6480464 | cobaltous chloride results in increased expression of KDM4B mRNA | CTD | PMID:22202117 |
| cyclophosphamide | multiple interactions | ISO | RGD:1349901 | 6480464 | KDM4B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| doxorubicin | multiple interactions | ISO | RGD:1349901 | 6480464 | KDM4B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1349901 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of KDM4B protein | CTD | PMID:18951874 |
| nickel dichloride | increases expression | ISO | RGD:1349901 | 6480464 | nickel chloride results in increased expression of KDM4B mRNA | CTD | PMID:17312168 |
| paclitaxel | multiple interactions | ISO | RGD:1349901 | 6480464 | KDM4B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| theophylline | multiple interactions | ISO | RGD:1349901 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of KDM4B protein | CTD | PMID:18951874 |
| trichostatin A | increases expression | ISO | RGD:1349901 | 6480464 | trichostatin A results in increased expression of KDM4B mRNA | CTD | PMID:15927959 |
| uranium atom | increases expression | ISO | RGD:1349901 | 6480464 | Uranium results in increased expression of KDM4B mRNA | CTD | PMID:15672453 |
| valproic acid | affects expression | ISO | RGD:1558448 | 6480464 | Valproic Acid affects the expression of KDM4B mRNA | CTD | PMID:20421339 |
| zinc atom | increases expression | ISO | RGD:1349901 | 6480464 | Zinc deficiency results in increased expression of KDM4B mRNA | CTD | PMID:18356318 |
| zinc dichloride | multiple interactions | ISO | RGD:1349901 | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of KDM4B mRNA] | CTD | PMID:22202117 |
| zinc(0) | increases expression | ISO | RGD:1349901 | 6480464 | Zinc deficiency results in increased expression of KDM4B mRNA | CTD | PMID:18356318 |